All In MedTech

Device Trial Radar · NCT04897035

Study to Evaluate the Safety and Effectiveness of Dayspring for Lower Extremity Lymphedema

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema

Last checked: Nov 20, 2026Latest source record: Feb 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

24

Actual

Start

Jun 1, 2021

Primary completion

Jun 30, 2022

Study completion Jul 1, 2022

Sponsor

Lead sponsor
Koya Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 21, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Koya Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema

Conditions

  • Lymphedema
  • Lymphedema Lower Extremity
  • Chronic Venous Insufficiency
  • Secondary Lymphedema

Interventions

  • Dayspring Active Wearable Compression SystemDevice

    Dayspring Active Wearable Compression System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. LYMQOL (LYMphedema Quality of Life) ***All Relevant Time Points Used in the Calculation in the Time Frame (e.g., Baseline and 3 Months).***Time frame: 3 months
  2. Change in Edema VolumeTime frame: 3 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • PT works

    Los Altos, California

  • Ginger-K Lymphedema & Cancer Center

    Morgan Hill, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.